Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (2019 - 2025)

Volitionrx's Shares Outstanding history spans 9 years, with the latest figure at $125.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 30.89% year-over-year to $125.8 million; the TTM value through Dec 2025 reached $125.8 million, up 30.89%, while the annual FY2025 figure was $125.8 million, 30.89% up from the prior year.
  • Shares Outstanding reached $125.8 million in Q4 2025 per VNRX's latest filing, up from $109.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $125.8 million in Q4 2025 to a low of $52.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $76.6 million, with a median of $78.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: grew 1.32% in 2022, then soared 45.11% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $53.8 million in 2021, then rose by 7.63% to $57.9 million in 2022, then skyrocketed by 41.51% to $81.9 million in 2023, then grew by 17.34% to $96.1 million in 2024, then surged by 30.89% to $125.8 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Shares Outstanding are $125.8 million (Q4 2025), $109.6 million (Q3 2025), and $104.0 million (Q2 2025).